Complete report is available @ http://www.reportsnreports.com/reports/279957-synta-pharmaceuticals-corp-product-pipeline-review-2014.html . Synta Pharmaceuticals Corp. - Product Pipeline Review – 2014 report provides comprehensive information on the current therapeutic developmental pipeline of Synta Pharmaceuticals Corp.’s Market, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

1. Synta Pharmaceuticals Corp. - Product Pipeline
Review - 2014
Order this report by calling
+1 888 391 5441 or Send an email
to sales@reportsandreports.com
with your contact details and
questions if any.
1© ReportsnReports.com / Contact sales@reportsandreports.com
Published: February 2014
Single User PDF: US$ 1500
Corporate User PDF: US$ 4500

2. Synta Pharmaceuticals Corp. –
Product Pipeline Review - 2014
Synta Pharmaceuticals Corp. - Product Pipeline Review – 2014 report provides
comprehensive information on the current therapeutic developmental pipeline of Synta
Pharmaceuticals Corp.’s Market, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
It also reviews latest updates, and featured news and press releases, along with special
features on late-stage and discontinued projects.
The report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced
from proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-
specific third party sources, put together.
2© ReportsnReports.com / Contact sales@reportsandreports.com
Reach us at
+ 1 888 391 5441 | sales@reportsandreports.com

3. Synta Pharmaceuticals Corp. –
Product Pipeline Review - 2014
Drug profiles/records featured in the report undergoes periodic updation following a
stringent set of processes that ensures that all the profiles are updated with the latest set
of information. Additionally, processes including live news & deals tracking, browser
based alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter
strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new
targets and MOAs to produce first-in-class and best-in-class products.
Browse more report on Pharmaceuticals Market
3© ReportsnReports.com / Contact sales@reportsandreports.com
Reach us at
+ 1 888 391 5441 | sales@reportsandreports.com

4. Synta Pharmaceuticals Corp. –
Product Pipeline Review - 2014
Scope
- The report provides brief overview of Synta Pharmaceuticals Corp. including business
description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Synta Pharmaceuticals Corp.’s human therapeutic
division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key
pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Synta Pharmaceuticals Corp.’s pipeline products
Get Discount on the Report @
http://www.reportsnreports.com/contacts/Discount.aspx?name=279957 .
4© ReportsnReports.com / Contact sales@reportsandreports.com
Reach us at
+ 1 888 391 5441 | sales@reportsandreports.com

5. Synta Pharmaceuticals Corp. –
Product Pipeline Review - 2014
Reasons to buy
- Evaluate Synta Pharmaceuticals Corp.’s strategic position with total access to detailed
information on its product pipeline
- Assess the growth potential of Synta Pharmaceuticals Corp. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Synta Pharmaceuticals Corp.’s
R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio
gaps
- Develop strategic initiatives by understanding the focus areas of Synta Pharmaceuticals
Corp. and exploit collaboration and partnership opportunities
Inquire before buying the Report @
http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=279957 .
5© ReportsnReports.com / Contact sales@reportsandreports.com
Reach us at
+ 1 888 391 5441 | sales@reportsandreports.com

6. Synta Pharmaceuticals Corp. –
Product Pipeline Review - 2014
Reasons to buy
- Identify emerging players with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of
Synta Pharmaceuticals Corp.
- Develop and design in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand business potential and
scope
- Explore the dormant and discontinued projects of Synta Pharmaceuticals Corp. and
identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Complete report is available @ http://www.reportsnreports.com/reports/279957-
synta-pharmaceuticals-corp-product-pipeline-review-2014.html .
6© ReportsnReports.com / Contact sales@reportsandreports.com
Reach us at
+ 1 888 391 5441 | sales@reportsandreports.com